Opioid activity profiles indicate similarities between the nociceptin/orphanin FQ and opioid receptors

European Journal of Pharmacology

Volumn 389, Issue 2-3, 2000, Pages 107-114

  Hawkinson, Jon E ^a   Acosta Burruel, Manuel ^a   Espitia, Stephen A ^a  

^a Department of Pharmacokinetics and Drug Metabolism   (United States)

Author keywords

GTP S; Nociceptin; Opioid; Opioid receptor; ORL1; Orphanin FQ

Indexed keywords

BETA HYDROXYMEFENTANYL; BUPRENORPHINE; ETORPHINE; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); LOFENTANIL; NALOXONE BENZOYLHYDRAZONE; NOCICEPTIN; NOCICEPTIN RECEPTOR; OPIATE AGONIST; OPIATE RECEPTOR; QUADAZOCINE; SUFENTANIL;

AGONIST; ANIMAL CELL; ARTICLE; BRAIN MEMBRANE; DRUG RECEPTOR BINDING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; FENTANYL; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HUMANS; MALE; NARCOTICS; OPIOID PEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID;

EID: 0034681395     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00904-8     Document Type: Article

References (38)

1. Adapa I.D., Toll L. Relationship between binding affinity and functional activity of nociceptin/orphanin FQ. Neuropeptides. 31:1997;403-408.
2. 125I-Tyr14-orphanin FQ with the orphanin FQ receptor: kinetics and modulation by cations and guanine nucleotides. Mol. Pharmacol. 51:1997;816-824.
3. 2 of G protein activation in rat brain preparations and of chronotropic effect on rat cardiomyocytes evoked by nociceptin/orphanin FQ. Br. J. Pharmacol. 126:1999;555-558.
4. Berzetei-Gurske I.P., White A., Polgar W., Decosta B.R., Pasternak G.W., Toll L. The in vitro pharmacological characterization of naloxone benzoylhydrazone. Eur. J. Pharmacol. 277:1995;257-263.
5. Butour J.-L., Moisand C., Mazarguil H., Mollereau C., Meunier J.-C. Recognition and activation of the opioid receptor-like ORL1 receptor by nociceptin, nociceptin analogs and opioids. Eur. J. Pharmacol. 321:1997;97-103.
6. Connor M., Vaughan C.W., Chieng B., Christie M.J. Nociceptin receptor coupling to a potassium conductance in rat locus coeruleus neurones in vitro. Br. J. Pharmacol. 119:1996;1614-1618.
7. Darland T., Heinricher M.M., Grandy D.K. Orphanin FQ/nociceptin: a role in pain and analgesia, but so much more. Trends Neurosci. 21:1998;215-221.
8. Dooley C.T., Houghten R.A. Orphanin FQ: receptor binding and analog structure activity relationships in rat brain. Life Sci. 59:1996;PL23-PL29.
9. Dunnill R.J., Kakizawa K., McNight A.T., Henderson G. Characterization of the actions of naloxone benzoylhydrazone at μ-opioid, κ-opioid and ORL1 receptors in isolated tissues from rat and guinea pig. Br. J. Pharmacol. 119:1996;275.
10. Evans C.J., Keith D.E., Morrison H., Magendzo K., Edwards R.H. Cloning of a delta opioid receptor by functional expression. Science. 258:1992;1952-1955.
11. Fawzi A.B., Zhang H.T., Weig B., Hawes B., Graziano M.P. Nociceptin activation of the human ORL1 receptor expressed in Chinese hamster ovary cells: functional homology with opioid receptors. Eur. J. Pharmacol. 336:1997;233-242.
12. Goldstein A., Naidu A. Multiple opioid receptors: ligand selectivity profiles and binding site signatures. Mol. Pharmacol. 36:1989;265-272.
13. Henderson G., McKnight A.T. The orphan opioid receptor and its endogenous ligandnociceptin/orphanin FQ. Trends Pharmacol. Sci. 18:1997;293-300.
14. Jenck F., Moreau J.-L., Martin J.R., Kilpatrick G.J., Reinscheid R.K., Monsma F.J., Nothacker H.-P., Civelli O. Orphanin FQ acts as an anxiolytic to attenuate behavioral responses to stress. Proc. Natl. Acad. Sci. U.S.A. 94:1997;14854-14858.
15. Kajiwara M., Aoki K., Ishii K., Numata H., Matsumiya T., Oka T. Agonist and antagonist actions of buprenorphine on three types of opioid receptor in isolated preparations. Jpn. J. Pharmacol. 40:1986;95-101.
16. Kapusta D.R., Sezen S.F., Chang J.-K., Lippton H., Kenigs V.A. Diuretic and antinatriuretic responses produced by the endogenous opioid-like peptide, nociceptin (orphanin FQ). Life Sci. 60:1996;PL15-PL21.
17. Kawamoto H., Ozaki S., Itoh Y., Miyaji M., Arai S., Nakashima H., Kato T., Ohta H., Iwasawa Y. Discovery of the first potent and selective small molecule opioid receptor-like (ORL1) antagonist: 1-[(3R,4R)-1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl]-3-ethyl-1,3-dihydro-2H-benzimidazol-2-one (J-113397). J. Med. Chem. 42:1999;5061-5063.
18. Kieffer B.L., Befort K., Gaveriaux-Ruff C., Hirth C.G. The δ-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. Proc. Natl. Acad. Sci. U.S.A. 89:1992;12048-12052.
19. Knoflach F., Reinscheid R.K., Civelli O., Kemp J.A. Modulation of voltage-gated calcium channels by orphanin FQ in freshly dissociated hippocampal neurons. J. Neurosci. 16:1996;6657-6664.
20. Maguire P., Tsai N., Kamal J., Cometta-Morini C., Upton C., Loew G. Pharmacological profiles of fentanyl analogs at μ, δ and κ opiate receptors. Eur. J. Pharmacol. 213:1992;219-225.
21. Meng F., Ueda Y., Hoversten M.T., Taylor L.P., Reinscheid R.K., Monsma F.J., Watson S.J., Civelli O., Akil H. Creating a functional opioid alkaloid binding site in the orphanin FQ receptor through site-directed mutagenesis. Mol. Pharmacol. 53:1998;772-777.
22. Meunier J.-C. Nociceptin/orphanin FQ and the opioid receptor-like ORL1 receptor. Eur. J. Pharmacol. 340:1997;1-15.
23. Meunier J.-C., Mollereau C., Toll L., Suaudeau C., Moisand C., Alvinerie P., Butour J.-L., Guillemot J.-C., Ferrara P., Monsarrat B., Mazarguil H., Vassart G., Parmentier M., Costentin J. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature. 377:1995;532-535.
24. Mollereau C., Parmentier M., Mailleux P., Butour J.-L., Moisand C., Chalon P., Caput D., Vassart G., Meunier J.-C. ORL1, a novel member of the opioid receptor family: cloning, functional expression and localization. FEBS Lett. 341:1994;33-38.
25. Nicholson J.R., Paterson S.J., McKnight A.T. Characterisation of the response in the rat vas deferens to the ORL1 agonist nociceptin. Br. J. Pharmacol. 119:1996;36.
26. Niwa M., Al-Essa L.Y., Ohta S., Kohno K.-I., Nozaki M., Tsurumi K., Iwamura T., Kataoka T. Opioid receptor interaction and adenylyl cyclase inhibition of dihydroetorphine: direct comparison with etorphine. Life Sci. 56:1995;PL395-PL400.
27. Pan Y.-X., Xu J., Ryan-Moro J., Mathis J., Hom J.S.H., Mei J., Pasternak G.W. Dissociation of affinity and efficacy in KOR-3 chimeras. FEBS Lett. 395:1996;207-210.
28. Peterson G.L. A simplification of the protein assay method of Lowry et al., which is more generally applicable. Anal. Biochem. 83:1977;346-356.
29. Pomonis J.D., Billington C.J., Levine A.S. Orphanin FQ, agonist of orphan opioid receptor ORL1, stimulates feeding in rats. NeuroReport. 8:1996;369-371.
30. Reinscheid R.K., Higelin J., Henningsen R.A., Monsma F.J., Civelli O. Structures that delineate orphanin FQ and dynorphin A pharmacological selectivities. J. Biol. Chem. 273:1998;1490-1495.
31. Reinscheid R.K., Nothacker H.P., Bourson A., Ardati A., Henningsen R.A., Bunzow J.R., Grandy D.K., Langen H., Monsma F.J., Civelli O. Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor. Science. 270:1995;792-794.
32. Sandin J., Georgieva J., Schött P.A., Ögren S.O., Terenius L. Nociceptin/orphanin FQ microinjected into hippocampus impairs spatial learning in rats. Eur. J. Neurosci. 9:1997;194-197.
33. Seki T., Awamura S., Kimura C., Ide S., Sakano K., Minami M., Nagase H., Satoh M. Pharmacological properties of TRK-820 on cloned μ-, δ- and κ-opioid receptors and nociceptin receptor. Eur. J. Pharmacol. 376:1999;159-167.
34. 35S]GTPγS binding in rat brain. NeuroReport. 7:1996;729-733.
35. Tian J.-H., Xu W., Fang Y., Mogil J.S., Grisel J.E., Grandy D.K., Han J.-S. Bidirectional modulatory effect of orphanin FQ on morphine-induced analgesia: antagonism in brain and potentiation in spinal cord of the rat. Br. J. Pharmacol. 120:1997;676-680.
36. Ward S.J., Pierson A.K., Michne W.F. Pharmacological profiles of tonazocine (Win 42156) and zenazocine (Win 42964). Neuropeptides. 5:1985;375-378.
37. Wnendt S., Krüger T., Janocha E., Hildebrandt D., Englberger W. Agonistic effect of buprenorphine in a nociceptin/OFQ receptor-triggered reporter gene assay. Mol. Pharmacol. 56:1999;334-338.
38. Wood P.L., Pilapil C., Thakur M., Richard J.W. WIN 44,441: a stereospecific and long-acting narcotic antagonist. Pharm. Res. 1:1984;46-48.